HANSOH PHARMA(HK:03692) Xin Lang Cai Jing·2026-02-02 10:49Core Viewpoint - Hansoh Pharmaceutical has been recognized for its outstanding performance in innovation, green production, environmental protection, social responsibility, and corporate governance, earning the title of "Green Leading Enterprise" and being included in the "Top 20 ESG Leading Samples" in Pudong New District's 2025 Environmental Performance Evaluation [1][4]. Group 1: Awards and Recognition - Hansoh Pharmaceutical is the only Chinese pharmaceutical company recognized as a "Green Leading Enterprise" among the evaluated entities [1][4]. - The "2025 ESG Leading Samples" evaluation was guided by various organizations, including the Shanghai Modern Service Industry Association and the Pudong New District Business Committee, with support from the Ministry of Commerce [2][5]. - The company has received high recognition from global authoritative institutions, maintaining an MSCI AA rating for several years and being listed in the S&P Global "Sustainability Yearbook" as one of the top 1% in the industry [3][6]. Group 2: ESG Practices and Contributions - Hansoh Pharmaceutical has significantly improved diagnostic capabilities and created social welfare in the treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD), which contributed to its selection in the "Top 20 ESG Leading Samples" [2][5]. - The Pudong New District has been enhancing its ESG evaluation system, encouraging enterprises to align with international standards and systematically improve their environmental, social, and governance development levels [2][5]. - As a key enterprise in the region, Hansoh Pharmaceutical actively participates in and shares its ESG practices, providing valuable examples and development paths for the pharmaceutical and related industries [2][5]. Group 3: Environmental Information Disclosure - In the 2025 Environmental Information Disclosure Ratings released by the global authoritative platform CDP, Hansoh Pharmaceutical achieved a dual B rating in climate change and water security, maintaining a leading position among Chinese pharmaceutical companies [3][7].